(Q41136385)

27 September 2017

1 reference

title

Value of digoxin in heart failure and sinus rhythm: new features of an old drug? (English)

1 reference

27 September 2017

0 references

4

Lie KI

1 reference

27 September 2017

van Veldhuisen DJ

1

1 reference

27 September 2017

de Graeff PA

series ordinal

2

1 reference

27 September 2017

Remme WJ

series ordinal

3

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

Journal of the American College of Cardiology

27 September 2017

published in

1 reference

27 September 2017

volume

28

1 reference

27 September 2017

issue

4

1 reference

27 September 2017

page(s)

813-819

1 reference

An account of the foxglove, and some of its medical uses:with practical remarks on dropsy, and other diseases

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digoxin in eurhythmic heart failure: PROVED or "not proven"?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Should digoxin be the drug of first choice after diuretics in chronic congestive heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis: dead or alive?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digoxin. A neurohormonal modulator in heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digoxin withdrawal in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

The management of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Therapeutic strategies and neurohormonal control in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Inotropic therapy for heart failure: paradise postponed

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Inotropic agents for heart failure: what if digoxin increases mortality?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

The development of positive inotropic agents for chronic heart failure: how have we gone astray?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

STUDIES ON DIGITALIS. X. EFFECTS OF OUABAIN ON FOREARM VASCULAR RESISTANCE AND VENOUS TONE IN NORMAL SUBJECTS AND IN PATIENTS IN HEART FAILURE

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis and the autonomic nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis and neurohormonal abnormalities in heart failure and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effect of digitalis on norepinephrine kinetics in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Role of renal Na+,K(+)-ATPase in the regulation of sodium excretion under normal conditions and in acute congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Acetylstrophanthidin-induced reflex inhibition of canine renal sympathetic nerve activity mediated by cardiac receptors with vagal afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Ouabain induces secretion of proatrial natriuretic factor by rat atrial cardiocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis and baroreceptor reflexes in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Modification of the baroreceptor control of atrio-ventricular conduction induced by digitalis in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis-induced augmentation of cardiopulmonary baroreflex control of forearm vascular resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effects of digoxin and enalapril on heart period variability and response to head-up tilt in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

How effective is digitalis in the treatment of congestive heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Pathophysiology and current therapy of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis. Mechanisms of action and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Heart failure in outpatients: a randomized trial of digoxin versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

A controlled trial of digoxin in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Long-term digitalis therapy improves left ventricular function in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease: a randomized, placebo-controlled, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digoxin in heart failure: implications of recent trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Review of randomized trials of digoxin therapy in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Ibopamine versus digoxin in the treatment of mild congestive heart failure. A double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digoxin for chronic heart failure: a review of the randomized controlled trials with special attention to the PROVED (Prospective Randomized Study of Ventricular Failure and the Efficacy of Digoxin) and RADIANCE (Randomized Assessment of Digoxin on

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effect of digitalis treatment on survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Dose-response relation between therapeutic levels of serum digoxin and systolic time intervals

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Clinical use of serum digoxin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis glycosides: mechanisms and manifestations of toxicity. Part III.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Hospitalizations with adverse events caused by digitalis therapy among elderly Medicare beneficiaries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Recognition and management of digitalis toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis-associated cardiac mortality after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Association of digitalis therapy with mortality in survivors of acute myocardial infarction: observations in the Beta-Blocker Heart Attack Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis--a new controversy regarding an old drug. The pitfalls of inappropriate methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Is digoxin an independent risk factor for long-term mortality after acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Hemodynamic Response to Acute Intravenous Digoxin in Patients with Recent Myocardial Infarction and Coronary Insufficiency with and without Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effects of captopril treatment on left ventricular remodeling and function after anterior myocardial infarction: comparison with digitalis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis and myocardial infarction in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Use of digitalis in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digitalis in Acute Myocardial Infarction: Help or Hazard?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Present status of digitalis treatment of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Studies on digitalis. XVI. Effects on myocardial oxygen consumption

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

The effect of ouabain on nutritional circulation and regional myocardial blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Increase in experimental infarct size with digoxin in a canine model of myocardial ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Cardiac and peripheral vascular effects of digitalis in clinical cardiogenic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Management of heart failure. I. Pharmacologic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Digoxin in the treatment of patients with chronic heart failure. Its place in therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900247-1

7 January 2021

10.1016/S0735-1097(96)00247-1

Identifiers

DOI

1 reference

27 September 2017

1 reference